MyAverix Finance
SA · Healthcare
Novo Nordisk A/S (N1VO34)
Drug Manufacturers - General
Novo Nordisk A/S (N1VO34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for N1VO34
Novo Nordisk A/S (N1VO34) — FAQ
What is N1VO34's P/E ratio?
The price-to-earnings (P/E) ratio for Novo Nordisk A/S (N1VO34) is 18.00 (data as of 2026-03-23).
Does Novo Nordisk A/S pay a dividend?
Dividend yield is not available in the current snapshot for Novo Nordisk A/S (N1VO34). Check the MyAverix Finance app for the latest dividend data.
What sector is Novo Nordisk A/S in?
Novo Nordisk A/S (N1VO34) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is N1VO34 listed on?
N1VO34 is listed on SA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.